Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
national blog main
biotech
boston top stories
clinical trials
life sciences
national top stories
new york blog main
san francisco blog main
cancer
deals
new york top stories
san diego blog main
san francisco top stories
sanofi
vertex pharmaceuticals
advance medical
american society of clinical oncology (asco)
american well
anti-inflammatory drugs
arcturus therapeutics
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
avrobio
best doctors
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer drugs
cancer immunotherapy
carlos nueno
colorectal cancer
crispr therapeutics
crispr-cas9
denali therapeutics
What
reach
4
×
cancer
cash
drug
ipo
medicines
acquisition
add
advance
ago
ahead
ambien
american
annual
asco
attendees
attention
based
biotech
biotechs
borders
bought
buys
camp’s
cancer’s
chicago
city
clinical
combinations
community’s
considering
data
days
deal
disease
diseases
dyne
early
expand
expanding
Language
unset
Current search:
reach
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More